Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma
Abstract
Authors
K. Fust X. Li M. Maschio G. Villa A. Parthan R. Barron M.C. Weinstein L. Somers C. Hoefkens G.H. Lyman